【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Overview: Respiratory diseases
• Asthma
• COPD
• Allergic rhinitis
• Pulmonary hypertension
• Cystic fibrosis
• IPF
• US FDA-approved respiratory drugs
PART 06: Pipeline analysis
• Information on some pipeline candidates
PART 07: Market landscape
• Five forces analysis
PART 08: Market segmentation by class of drugs
• Bronchodilators
• Leukotriene antagonists
• Mast cell stabilizers
• Immunosuppressants
• Combination of LABA/ICS
• Tyrosine kinase inhibitors
• Antifibrotic agents
• Antihistamines
• Endothelin (ET) receptor antagonist
• Prostacyclin analogs
• Phosphodiesterase inhibitors
• Soluble guanylate cyclase (sGC) stimulators
PART 09: Market segmentation by disease
• Global asthma drugs market
• Global COPD drugs market
• Global allergic rhinitis drugs market
• Global pulmonary hypertension drugs market
• Global cystic fibrosis drugs market
• Global IPF drugs market
PART 10: Geographical segmentation
• Global respiratory drugs market by geography 2015-2020
• Respiratory drugs market in Americas
• Respiratory drugs market in EMEA
• Respiratory drugs market in APAC
PART 11: Market drivers
• Promising late-stage pipeline molecules
• Rise in prevalence of respiratory diseases
• Increase in older adult population
• High usage of tobacco
• Increase in environmental pollution
PART 12: Impact of drivers
PART 13: Market challenges
• Multiple patent expiries
• Unknown etiology of asthma and IPF
• Low diagnosis rates
• Adverse effects of drugs
• Increased preference for CAM
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Increasing awareness about respiratory diseases
• Patient assistance programs
• Usage of biologics
• Self-medication using OTC products
• Strategic alliances
PART 16: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• AstraZeneca
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Merck
• Novartis
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Objectives of asthma management
Exhibit 03: COPD: Prevalence in six EU countries
Exhibit 04: Management of COPD
Exhibit 05: Prevalence rate of allergic rhinitis in China
Exhibit 06: Summary of pharmacologic treatments for allergic rhinitis
Exhibit 07: Non-pharmacological therapies for allergic rhinitis
Exhibit 08: Prevalence of cystic fibrosis by country 2014
Exhibit 09: Treatment options for IPF
Exhibit 10: Drugs approved by US FDA for respiratory diseases 2000-2015
Exhibit 11: Pipeline portfolio of major drug candidates for respiratory diseases
Exhibit 12: Global respiratory drugs market 2015-2020 ($ billions)
Exhibit 13: Global respiratory drugs market by diseases 2015
Exhibit 14: Five forces analysis
Exhibit 15: Global asthma drugs market 2015-2020 ($ billions)
Exhibit 16: Key drivers and challenges of global asthma drugs market
Exhibit 17: Global asthma drugs market by class of drugs 2015
Exhibit 18: Global COPD drugs market 2015-2020 ($ billions)
Exhibit 19: Key drivers and challenges of global COPD drugs market
Exhibit 20: Global COPD drugs market by class of drugs 2015
Exhibit 21: Global allergic rhinitis drugs market 2015-2020 ($ billions)
Exhibit 22: Key drivers and challenges of global allergic rhinitis drugs market
Exhibit 23: Global allergic rhinitis drugs market by class of drugs 2015
Exhibit 24: Global pulmonary hypertension drugs market 2015-2020 ($ billions)
Exhibit 25: Key drivers and challenges for global pulmonary hypertension drugs market
Exhibit 26: Global pulmonary hypertension drugs market by class of drugs 2015
Exhibit 27: Global cystic fibrosis drugs market 2015-2020 ($ billions)
Exhibit 28: Key drivers and challenges for global cystic fibrosis drugs market
Exhibit 29: Global cystic fibrosis drugs market by type of molecule 2015
Exhibit 30: Global IPF market 2015-2020 ($ billions)
Exhibit 31: Key drivers and challenges for global IPF drugs market
Exhibit 32: Global respiratory drugs market: YoY revenue and growth based on respiratory diseases 2015-2020
Exhibit 33: Global respiratory drugs market by geography 2015
Exhibit 34: Global respiratory drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 35: Respiratory drugs market in Americas 2015-2020 ($ billions)
Exhibit 36: Respiratory drugs market in EMEA 2015-2020 ($ billions)
Exhibit 37: Respiratory drugs market in APAC 2015-2020 ($ billions)
Exhibit 38: Global respiratory drugs market; YoY revenue and growth based on geography 2015-2020
Exhibit 39: Impact of drivers
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Drugs that converted from Rx to OTC
Exhibit 42: Global respiratory drugs market share analysis 2015
Exhibit 43: Top selling respiratory drugs based on their revenue in 2014
Exhibit 44: AstraZeneca: Percentage share of products sales by therapy area 2014
Exhibit 45: AstraZeneca: YoY growth and revenue of Symbicort 2012-2014 ($ billions)
Exhibit 46: AstraZeneca: YoY growth and revenue of Pulmicort 2012-2014 ($ billions)
Exhibit 47: AstraZeneca: Key takeaways
Exhibit 48: Boehringer Ingelheim: YoY growth and revenue of Spiriva 2012-2014 ($ billions)
Exhibit 49: Boehringer Ingelheim: YoY growth and revenue of Combivent 2012-2014 ($ millions)
Exhibit 50: Boehringer Ingelheim: Key takeaways
Exhibit 51: F. Hoffmann-La Roche: YoY growth and revenue of Xolair in the US 2012-2014 ($ millions)
Exhibit 52: F. Hoffmann-La Roche: YoY growth and revenue of Pulmozyme 2012-2014 ($ millions)
Exhibit 53: F. Hoffmann-La Roche: Key takeaways
Exhibit 54: GlaxoSmithKline: Percentage share of products sales by therapy area 2014
Exhibit 55: GlaxoSmithKline: YoY growth and revenue of Seretide/Advair 2012-2014 ($ billions)
Exhibit 56: GlaxoSmithKline: YoY growth and revenue of Flixotide/Flovent 2012-2014 ($ billions)
Exhibit 57: GlaxoSmithKline: YoY growth and revenue of Ventolin 2012-2014 ($ billions)
Exhibit 58: GlaxoSmithKline: YoY growth and revenue of Avamys/Veramyst 2012-2014 ($ millions)
Exhibit 59: GlaxoSmithKline: YoY revenue of Avamys/Veramyst 2013 and 2014 ($ millions)
Exhibit 60: GlaxoSmithKline: Key takeaways
Exhibit 61: Merck: YoY growth and revenue of Nasonex 2012-2014 ($ billions)1
Exhibit 62: Merck: YoY growth and revenue of Singulair 2012-2014 ($ billions)2
Exhibit 63: Merck: YoY growth and revenue of Clarinex 2012-2014 ($ millions)2
Exhibit 64: Merck: Key takeaways4
Exhibit 65: Novartis: YoY growth and revenue of Xolair (outside the US) 2012-2014 ($ millions)6
Exhibit 66: Novartis: YoY growth and revenue of TOBI 2012-2014 ($ millions)6
Exhibit 67: Novartis: YoY growth and revenue of Onbrez Breezhaler 2012-2014 ($ millions)7
Exhibit 68: Novartis: YoY growth and revenue of Seebri Breezhaler 2012-2014 ($ millions)7
Exhibit 69: Novartis: YoY revenue of Ultibro Breezhaler 2013 and 2014 ($ millions)8
Exhibit 70: Novartis: YoY growth and revenue of Foradil Aerolizer sold outside the US 2012-2014 ($ millions)8
Exhibit 71: Novartis: Key takeaways9
【レポート販売概要】
■ タイトル：呼吸器疾患治療薬の世界市場：喘息、COPD、アレルギー性鼻炎、肺高血圧症、嚢胞性繊維症、IPF■ 英文：Global Respiratory Drugs Market 2016-2020
■ 発行日：2016年5月4日
■ 調査会社：Technavio
■ 商品コード：IRTNTR8439
■ 調査対象地域：グローバル
- 無菌包装の世界市場2016-2020About Aseptic Packaging Aseptic packaging refers to the packaging of sterile products in pre-sterilized containers in an aseptic external environment, to ensure that the products remain free from contamination for a long period of time. The aseptic external environment includes filling machines and equipment required for packaging. This kind of packaging involves flash pasteurization of products s …
- 脊柱用生物製剤の世界市場：骨移植片、骨移植片代用品、BMAC（骨髄穿刺液）The report on global spinal biologics market analyzes and segments the market on the basis of product, surgery type, and region. It analyzes the competitive developments, such as alliances, joint ventures, and mergers & acquisitions in the global spine biologics market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments. The spin …
- 世界の殺線虫剤市場2015The Global Nematicides Industry Report 2015 is a professional and in-depth study on the current state of the Nematicides industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Nematicides market analysis is provided for the international markets including development trends, competitive landscape analysis …
- 医薬品開発業務受託機関（CRO）市場：M&A動向、戦略Contract Research Organization Market - Global Deals and Operational Strategies Summary GBI Research’s latest report, "Contract Research Organization Market - Global Deals and Operational Strategies" discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more than 40 public and privately held CROs. The operational strategies adopted by key pl …
- 胎児モニタリング製品の世界市場：超音波胎児モニタ、電子モニタ、胎児用電極、胎児心拍計測器、子宮収縮モニタ、遠隔測定装置The fetal monitoring market is expected to reach $2,346.4 million by 2019 from $1,688.7 million in 2014, at a CAGR of 6.8%. The global fetal monitoring market is segmented based on products, portability, methods, applications, end users, and geography. The electronic fetal monitors segment is expected to register the highest growth rate in the fetal monitoring market, by product, during the foreca …
- 世界の医療オートメーション市場The global medical automation market is segmented on the basis of application, end users, and geography. The applications market is further segmented into diagnostics and monitoring automation, therapeutic automation, lab and pharmacy automation, and logistics and training automation. Based on end users, the market is segmented into hospitals and diagnostic centers, pharmacies, research labs and i …
- 世界のNAND型フラッシュメモリ市場動向（2014～2018）TechNavio's analysts forecast the Global 3D NAND Flash Memory market to grow at a CAGR of 180.7 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in memory requirements and demand for low form factor NAND flash memory. The Global 3D NAND Flash Memory market has also been witnessing increased R&D spending by vendors. However, the low adopti …
- マラリア検査の世界市場2015The report presents a detailed analysis of the Malaria diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Malaria definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - …
- 耐熱ガスケットの世界市場：材料別（黒鉛、フルオロシリコン、ガラス繊維、セラミック、雲母、テフロン、その他）、製品別（金属、半金属、非金属、UHT液体ガスケット）、デザイン別（渦巻き形、缶プロファイル、ダブルジャケット、フィッシュボーン、 その他）、地域別予測Global High-Temperature Gaskets Market to reach USD 31.8 billion by 2025. Global High-Temperature Gaskets Market valued approximately USD 20.4 billion in 2016 is forecasted to grow with a healthy growth rate of more than 5.5% over the forecast period 2018-2025. The major factors speculated to augment the markets are severe leakage regulations implemented by the EPA to restrain damage to the enviro …
- ギャレー（調理室）装置の世界市場2017-2021About Galley Equipment The galley is an area in an aircraft or ship, where the food is prepared and cooked. The electric and non-electric equipment used in the galley area is termed as galley equipment. The global galley equipment market is segmented based on its applications into aviation segment and marine segment. The galley equipment market in the marine segment accounts for strong revenue sha …
- Talisman Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Talisman Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Talisman Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- Vaginal Cancer：グローバル臨床試験レビューH2, 2013Vaginal Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Vaginal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vaginal Cancer. It includes an overview of the trial numbers and their recruitment status as per …
- 飼料用酵母の世界市場展望2017-2026According to Stratistics MRC, the Global Feed Yeast market is accounted for $1.61 billion in 2017 and is expected to reach $3.10 billion by 2026 growing at a CAGR of 7.5% during the forecast period. The factors driving the market growth are increasing concerns related to animal health and high growth of yeast-based feed products. However, competitions of raw materials are restraining the market. Y …
- 世界の精密空調市場動向（2012-2016）TechNavio's analysts forecast the Global Precision Air Conditioning market to grow at a CAGR of 11.90 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing data center heat density. The Global Precision Air Conditioning market has also been witnessing the emergence of spot cooling equipment. However, the huge capital investment required to a …
- 産業用ボイラーの世界市場予測2026：水管ボイラー、煙管ボイラーThe industrial boilers market is estimated to be USD 10.92 Billion in 2016 and is projected to reach USD 17.77 Billion by 2026, at a CAGR of 5.0% between 2016 and 2026. Factors such as increasing demand for clean energy sources, increasing number of natural power plants, and government initiatives to promote clean energy and reduce dependency on fossil fuels are key factors expected to boost the g …
